Direct acting antivirals for the treatment of hepatitis C in ethnic minority populations

Expert Opinion on Pharmacotherapy
Julius M Wilder, Andrew J Muir

Abstract

Direct acting antivirals (DAA's) have revolutionized the treatment of hepatitis C (HCV). However, questions persist concerning their efficacy in minority populations. In this review, the authors review outcomes for treatment of HCV by race and ethnicity among the clinical trials that have led to the current recommended treatments for HCV. The authors highlight the efficacy and safety differences by race and ethnicity. They also highlight deficiencies within the literature including small populations of racial/ethnic minorities within HCV clinical trials. DAA's can achieve cure rates for HCV over 95% with the use of once daily medications that have minimal side effects and few significant drug-drug interactions. Regimens with high pan-genotypic efficacy have further simplified treatment paradigms. The purpose of this review is to describe the data on DAA's in treating HCV in racial/ethnic populations. While the overall data in racial/ethnic minority populations is sparse, DAA's appear to have high efficacy in curing HCV in diverse racial/ethnic populations. Although achieving high sustained virologic response (SVR) rates, there are also data that suggests that some disparities in SVR persist, especially when considering shorter ...Continue Reading

References

May 28, 2004·The New England Journal of Medicine·Andrew J MuirUNKNOWN Atlantic Coast Hepatitis Treatment Group
Jun 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lennox J JeffersK Rajender Reddy
May 17, 2006·Annals of Internal Medicine·Gregory L ArmstrongMiriam J Alter
Aug 8, 2006·Gastroenterology·Hari S ConjeevaramUNKNOWN Virahep-C Study Group
Jan 16, 2009·The New England Journal of Medicine·Maribel Rodriguez-TorresUNKNOWN Latino Study Group
Mar 31, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marc G GhanyUNKNOWN American Association for the Study of Liver Diseases
Jun 30, 2009·The American Journal of Medicine·Andy I ChoiAnn M O'Hare
Aug 7, 2010·The Journal of Antimicrobial Chemotherapy·Susanna NaggieJohn McHutchison
Apr 1, 2011·The New England Journal of Medicine·Fred PoordadUNKNOWN SPRINT-2 Investigators
Jun 24, 2011·The New England Journal of Medicine·Ira M JacobsonUNKNOWN ADVANCE Study Team
Nov 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Khayriyyah Mohd HanafiahSteven T Wiersma
Apr 16, 2013·Gastroenterology·Sumeet K AsraniW Ray Kim
Apr 24, 2013·The New England Journal of Medicine·Eric LawitzEdward J Gane
Dec 24, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·George N IoannouPamela K Green
Apr 12, 2014·The New England Journal of Medicine·Kris V KowdleyUNKNOWN ION-3 Investigators
Apr 12, 2014·The New England Journal of Medicine·Jordan J FeldBarry Bernstein
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-2 Investigators
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-1 Investigators
May 16, 2014·Journal of Clinical Gastroenterology·Steven L FlammGeoffrey M Dusheiko
Sep 3, 2014·The American Journal of Gastroenterology·Sammy SaabFritz Francois
Jul 22, 2015·The New England Journal of Medicine·Susanna NaggieUNKNOWN ION-4 Investigators
Nov 9, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Julius M WilderK Rajender Reddy
Nov 17, 2015·Therapeutic Advances in Chronic Disease·Julius M Wilder, Andrew J Muir
Nov 17, 2015·The New England Journal of Medicine·Michael P CurryUNKNOWN ASTRAL-4 Investigators
Nov 18, 2015·The New England Journal of Medicine·Graham R FosterUNKNOWN ASTRAL-3 Investigators
Mar 2, 2016·Journal of the National Medical Association·Julius WilderAndrew Muir
Jun 16, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Veronica Wendy SetiawanMazen Noureddin
Oct 25, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Feng SuGeorge N Ioannou

❮ Previous
Next ❯

Citations

Apr 4, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Poonam Mathur, Shyam Kottilil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Related Papers

Expert Opinion on Investigational Drugs
Ameer Abutaleb, Shyamasundaran Kottilil
Expert Opinion on Pharmacotherapy
Elana S RosenthalMichael A Polis
Gastroenterology
Gregory J DoreAustralian Trial In Acute Hepatitis C Study Group
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Curtis Cooper
© 2022 Meta ULC. All rights reserved